Halofantrine Hydrochloride

盐酸卤泛群

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHalofantrine Hydrochloride
Drug Alias Namehalofantrinum卤泛群盐酸盐halofantrina卤泛曲林卤方特瑞 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv11.1 blockers
TargetsVoltage-gated potassium channel subunit Kv11.1
Therapy Area/IndicationsMalaria
Global Approved IndicationsMalaria
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1992/07/24
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeP01BX01
Related LinksWikipediaDrugBankKEGG